Enhances availability of device therapy options, particularly for those who struggle with single pressure PAP therapyPart of Air11 Solutions, key features include Care Check-in, Personal Therapy Assistant, among others to provide support to patients and insights to clinicians and providers when used with AirView and myAir app SAN DIEGO, Feb.

增强了设备治疗选项的可用性，特别是对于那些在单压巴氏治疗中挣扎的人，Air11解决方案的主要功能包括护理登记、个人治疗助理等，当与AirView和myAir应用程序一起使用时，可为患者提供支持，并为临床医生和提供者提供见解圣地亚哥，2月。

12, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) launched today its AirCurve 11 series devices, the company’s newest bilevel devices that use two levels of support, inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP), combined with digital technology to make it easier for healthcare providers to treat sleep apnea and to help patients start and stay on therapy.

122024（环球通讯社）--ResMed（纽约证券交易所：RMD，澳大利亚证券交易所：RMD）今天推出了其AirCurve 11系列设备，该公司最新的双层设备使用两种支持水平，即吸气正压（IPAP）和呼气正压（EPAP），与数字技术相结合，使医疗保健提供者更容易治疗睡眠呼吸暂停，并帮助患者开始和继续治疗。

AirCurve 11 devices are built on ResMed’s market-leading AirSense 11 platform and enhance the suite of offerings available for healthcare providers and clinicians when determining the best care for sleep apnea patients. Addressing the challenges that some patients have adapting to CPAP therapy, the AirCurve 11 VAuto is a bilevel PAP device designed to improve comfort and help compliance by providing a higher pressure during inhalation and a lower pressure during exhalation.

AirCurve 11设备建立在ResMed市场领先的AirSense 11平台上，在确定睡眠呼吸暂停患者的最佳护理时，增强了医疗保健提供者和临床医生可用的一套产品。针对一些患者适应CPAP治疗的挑战，AirCurve 11 VAuto是一种双层PAP装置，旨在通过在吸入过程中提供更高的压力和在呼气过程中提供更低的压力来提高舒适度并帮助依从性。

This design allows the device to align more closely with the patient’s natural breathing pattern. The AirCurve11 ASV1, ResMed’s new adaptive servo-ventilation (ASV) device, makes therapy feel like the patient’s own breath – which is critical for patients who present with central sleep apnea, obstructive sleep apnea, mixed apneas or periodic breathing.

这种设计使设备能够与患者的自然呼吸模式更紧密地对齐。ResMed的新型自适应伺服通气（ASV）设备AirCurve11 ASV1使治疗感觉就像患者自己的呼吸，这对于患有中枢性睡眠呼吸暂停、阻塞性睡眠呼吸暂停、混合性呼吸暂停或周期性呼吸的患者至关重要。

These patients often find that standard therapies are often unable to fully normalize their breathing. The ASVAuto algorithm tracks 13 points on every breath cycle 50 times per second, using each patient’s uniq.

这些患者经常发现标准疗法通常无法完全使他们的呼吸正常化。ASVAuto算法使用每个患者的uniq，每秒50次跟踪每个呼吸周期的13个点。